Baxter Ventures
Overview
Baxter Ventures is the venture capital arm of Baxter International, investing in companies with innovative technologies, products, and therapies that accelerate growth and advance patient care . The firm focuses on therapeutic areas complementary to Baxter's presence in critical, hospital, nutritional, renal and surgical care, as well as cutting-edge technology and therapies outside of Baxter's current product portfolio .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Merna Therapeutics | Apr 2015 | Series D | Lead |
| Bluesight | Jun 2016 | Series C | Lead |
| Outset Medical | Aug 2018 | Series D | Co-investor |
| ProMedix | Mar 2022 | Accelerator | Co-investor |
| VitalConnect | Oct 2017 | Series C | Lead |
For institutional investors. Book with your work email.
Key People
Giuseppe Accogli
EVP & Chief Operating Officer, Senior Vice President & President, Americas & Global Business Units
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Baxter Ventures based?
Baxter Ventures is headquartered in Deerfield, Illinois, United States.
When was Baxter Ventures founded?
Baxter Ventures was founded in 2011.
How many portfolio companies does Baxter Ventures have?
Baxter Ventures has 7 portfolio companies in Caplight's dataset.
What are some companies in Baxter Ventures's portfolio?
Portfolio companies visible on Caplight include Merna Therapeutics, Bluesight, Outset Medical, ProMedix, VitalConnect.
What was Baxter Ventures's most recent investment shown here?
Baxter Ventures's most recent investment in this portfolio sample was in ProMedix in 2022.
What sectors does Baxter Ventures focus on?
Baxter Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software.
What company stages does Baxter Ventures focus on?
Baxter Ventures typically invests at the Mid stage.
What is Baxter Ventures's AUM?
Baxter Ventures's assets under management are estimated between $0.0 and $50.0M.